Mawallafi: Janice Evans
Ranar Halitta: 2 Yuli 2021
Sabuntawa: 16 Nuwamba 2024
Anonim
Decomposition of the Red Grapefruit Juice - time lapse (sok z czerwonego grejpfruta)
Video: Decomposition of the Red Grapefruit Juice - time lapse (sok z czerwonego grejpfruta)

Wadatacce

Pea Graan itacen inabi ɗan itaciya ne. Mutane suna amfani da thea fruitan itace, mai daga ɓawon, da ruwan 'ya'yan iri a matsayin magani. Ana sarrafa tsaba daga peapean itacen inabi daga seedsa graan itacen inabi da kuma ɓangaren litattafan almara waɗanda aka samo a matsayin kayan amfanin gona daga juicea juicean ruwan inabi. An kara glycerin kayan lambu a kayan karshe don rage yawan acidity da daci.

Auren peapean itacen inabi ana yawan shan ta don bakin nauyi. Hakanan ana amfani dashi don asma, babban cholesterol, ciwon daji, da sauran yanayi, amma babu wata kyakkyawar shaidar kimiyya da zata goyi bayan waɗannan abubuwan amfani.

A cikin abinci da abubuwan sha, ana amfani da itacen inabi a matsayin fruita fruitan itace, ruwan 'ya'yan itace, kuma ana amfani dashi azaman ɓangaren dandano.

A cikin masana'antu, ana amfani da man inabi da cirewar iri a matsayin kayan ƙanshi a sabulai da kayan shafawa; kuma a matsayin mai tsabtace gida ga fruitsa fruitsan itace, kayan marmari, nama, shimfidar kicin, abinci, da sauransu.

A harkar noma, ana amfani da tsinken giyar inabi don kashe ƙwayoyin cuta da naman gwari, yaƙi da haɓakar ƙwayar cuta, kashe ƙwayoyin cuta a cikin abincin dabbobi, adana abinci da kuma kashe ruwa.

Yana da mahimmanci a tuna cewa hulɗar miyagun ƙwayoyi tare da ruwan inabi suna rubuce sosai. Kimiyyar sinadarin inabi ta bambanta ta jinsin, yanayin girma, da kuma hanyar da ake amfani da ita don tsinke ruwan 'ya'yan itace. Kafin saka graapeapeapea graapeapeyan itacen inabi a cikin abincinka ko jerin magunguna na ƙasa, bincika likitanka idan ka sha magunguna.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don GAREHUL sune kamar haka:


Yiwuwar tasiri ga ...

  • Kiba. Samun takamaiman samfurin dauke da lemu mai zaki, lemu na jini, da ruwan 'ya'yan inabi kamar yana rage nauyin jiki da kitse a jikin mutane masu kiba. Wani bincike kuma ya nuna cewa cin ɗanyen ɗanyun itace a kowace rana yana ƙara rage nauyi a cikin mutane masu kiba.

Evidencearancin shaida don kimanta inganci don ...

  • Asthma. Wasu bincike sun nuna cewa cin 'ya'yan itacen Citrus mai wadataccen bitamin C, gami da' ya'yan inabi da sauransu, na iya inganta aikin huhu a cikin masu fama da asma. Amma sauran karatun basu nuna wannan fa'idar ba.
  • Cancanta (atopic dermatitis). Bincike na farko ya nuna cewa cirewar graapean itacen inabi na iya rage maƙarƙashiya, gas, da rashin jin daɗin ciki ga mutane masu eczema. Wannan fa'idar na iya zama sakamakon tasirin 'ya'yan inabi ne akan kwayoyin cuta na hanji.
  • Babban cholesterol. Binciken farko ya nuna cewa shan pectin grapefruit a kullum na tsawon makonni 16 yana rage yawan cholesterol da kuma yawan kwayar kwayar mai karamin karfi (LDL ko "mara kyau") cholesterol zuwa babban kwalastrol (HDL ko "mai kyau") cholesterol idan aka kwatanta da asalin.
  • Babban matakan mai da ake kira triglycerides a cikin jini (hypertriglyceridemia). Cin inabi daya a kowace rana ya bayyana don rage yawan cholesterol, low-density lipoprotein (LDL ko "bad") cholesterol, da matakan triglyceride a cikin mutanen da ke da matakan triglyceride masu yawa.
  • Kwarkwata. Binciken farko ya nuna cewa shafa shamfu mai dauke da 'ya'yan inabi a gashin gashin yara na tsawon minti 10-20 na kashe kwarkwata. Sake amfani da shamfu bayan kwanaki 10 daga baya yana taimakawa cire duk sauran nits.
  • Kuraje.
  • Bacin rai.
  • Gunaguni na narkewa a cikin mutane tare da eczema.
  • Eningarfafa jijiyoyin jini (atherosclerosis).
  • Ciwon kai.
  • Cututtuka.
  • Gajiyawar tsoka.
  • Tsayar da ciwon daji.
  • Inganta ci gaban gashi.
  • Psoriasis.
  • Danniya.
  • Toning fata.
  • Cututtukan yisti na farji.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta tasirin ɗan itacen inabi don waɗannan amfanin.

An itacen inabi itace tushen bitamin C, fiber, potassium, pectin, da sauran abubuwan gina jiki. Wasu abubuwan haɗin zasu iya samun tasirin antioxidant wanda zai iya taimakawa kare ƙwayoyin daga lalacewa ko rage cholesterol.

Ba a bayyana yadda man zai yi aiki don amfanin magani ba.

Lokacin shan ta bakin: Graa Graan inabi ne LAFIYA LAFIYA a cikin adadin da aka saba amfani dashi azaman abinci da MALAM LAFIYA lokacin da aka sha da baki a matsayin magani. Amma ɗan itacen inabi ne YIWU KA KIYAYE lokacin da aka ɗauke ta baki da yawa.

Idan ka sha kowane magani, sai ka duba likitanka kafin ka kara 'ya'yan inabi a cikin abincinka ko amfani da shi azaman magani. Inabi yana hulɗa tare da dogon jerin magunguna (duba "Shin akwai hulɗa tare da magunguna?" A ƙasa).

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Ba a san isa game da amfani da ofapean itacen inabi a lokacin daukar ciki da shayar da nono ba. Kasance a gefen aminci ka guji amfani.

Ciwon nono: Akwai damuwa game da amincin shan yawancin ruwan inabi. Wasu bincike sun nuna cewa matan da basu gama aure ba wadanda suke shan kwari ko fiye na ruwan 'ya'yan inabi a kowace rana suna da damar karin 25% zuwa 30% na kamuwa da cutar sankarar mama. Ruwan 'ya'yan itacen inabi yana rage yadda estrogen yake lalacewa a jiki kuma yana iya kara yawan isrogen cikin jiki. Ana buƙatar ƙarin bincike don tabbatar da waɗannan binciken. Har sai an san wasu, kauce wa shan ruwan inabi mai yawa, musamman idan kana da cutar sankarar mama ko kuma kana cikin haɗarin da ya saba kamuwa da cutar kansa ta mama.

Cututtukan tsokar zuciya: Cinye ruwan inabi na iya ƙara yiwuwar bugun zuciya mara kyau. Mutanen da ke fama da waɗannan cututtukan ya kamata su sha ruwan inabi a matsakaici.

Ciwon daji mai saurin damuwa da yanayi: Yin amfani da ruwan inabi mai yawa na iya ƙara matakan hormone sabili da haka yana ƙara haɗarin yanayin yanayin damuwa na hormone. Mata masu yanayin damuwa na hormone ya kamata su guji 'ya'yan inabi.

Bugun zuciya mara tsari: Cinye yawancin 'ya'yan inabi ko ruwan' ya'yan itace na iya kara bugun zuciya mara tsari. Kar ayi amfani da inabi idan kana da wannan yanayin.

Manjo
Kada ku ɗauki wannan haɗin.
Amiodarone (Cordarone)
Ruwan inabi na iya kara yawan amiodarone (Cordarone) da jiki ke sha. Shan ruwan inabi yayin shan amiodarone (Cordarone) na iya kara tasirin da tasirin. Guji shan ruwan inabi idan kuna shan amiodarone (Cordarone).
Artemether (Artenam, Paluther)
Jiki yana rushe artemether (Artenam, Paluther) don kawar da shi. Ruwan pea Graan itacen inabi na iya rage yadda sauri jiki ke rushe artemether (Artenam, Paluther). Shan ruwan inabi yayin shan artemether (Artenam, Paluther) na iya kara illoli da illar artemether (Artenam, Paluther). Kada ku sha ruwan inabi idan kuna shan artemether (Artenam, Paluther).
Atorvastatin (Lipitor)
Atorvastatin (Lipitor) wani nau'i ne na rage ƙwayar cholesterol wanda aka sani da "statin." Jiki yana rushe atorvastatin (Lipitor) don kawar dashi. Ruwan inabi na iya rage yadda sauri jiki ke rushe atorvastatin (Lipitor). Shan ruwan inabi yayin shan atorvastatin (Lipitor) na iya kara tasiri da illolin wannan magani.
Buspirone (BuSpar)
Ruwan inabi na iya kara yawan buspirone (BuSpar) da jiki ke sha. Shan ruwan 'ya'yan inabi yayin shan buspirone (BuSpar) na iya kara sakamako da illar buspirone (BuSpar).
Carbamazepine (Tegretol)
Ruwan inabi na iya kara yawan carbamazepine (Tegretol) da jiki ke sha. Shan ruwan inabi yayin shan carbamazepine (Tegretol) na iya ƙara sakamako da illolin carbamazepine (Tegretol).
Carvedilol (Coreg)
Jiki yana rushe carvedilol (Coreg) don kawar da shi. Ruwan pea Graan itacen inabi kamar yana rage yadda sauri jiki ke rushe carvedilol (Coreg). Shan ruwan inabi yayin shan carvedilol (Coreg) na iya kara illoli da kuma illolin carvedilol (Coreg).
Celiprolol (Celicard)
A Graan itacen inabi ya bayyana ya rage nawa celiprolol (Celicard) ke sha. Wannan na iya rage tasirin celiprolol (Celicard). Raba gudanarwar mulkin celiprolol (Celicard) da cin inabi da aƙalla awanni 4.
Cisapride (Propulsid)
Juiceauren Graapean itacen inabi na iya rage yadda sauri jiki ke kawar da cisapride (Propulsid). Shan ruwan inabi yayin shan cisapride (Propulsid) na iya kara tasiri da illar cisapride (Propulsid).
Clomipramine (Anafranil)
Jiki yana lalata clomipramine (Anafranil) don kawar da shi. Ruwan inabi na iya rage yadda sauri jiki ke kawar da clomipramine (Anafranil). Shan ruwan 'ya'yan inabi tare da clomipramine (Anafranil) na iya kara tasiri da illolin clomipramine (Anafranil).
Clopidogrel (Plavix)
Clopidogrel (Plavix) kayan aiki ne. Abubuwan buƙata suna buƙatar kunnawa jiki don aiki. Auren peapean itacen inabi ya bayyana ya rage nawa clopidogrel (Plavix) ke kunnawa da jiki. Wannan na iya haifar da rage tasirin clopidogrel. Kada ku ɗauki 'ya'yan inabi tare da clopidogrel.
Cyclosporine (Neoral, Sandimmune)
Abapea na iya kara yawan cyclosporine (Neoral, Sandimmune) da jiki ke sha. Shan ruwan inabi yayin shan cyclosporine (Neoral, Sandimmune) na iya ƙara tasirin tasirin cyclosporine.
Dextromethorphan (Robitussin DM, da sauransu)
Jiki yana lalata dextromethorphan (Robitussin DM, wasu) don kawar da shi. Pea Graan itacen inabi na iya rage yadda sauri jiki ke rushewar dextromethorphan (Robitussin DM, wasu). Shan ruwan inabi yayin shan dextromethorphan (Robitussin DM, wasu) na iya kara tasiri da illolin dextromethorphan (Robitussin DM, wasu).
Estrogens
Jiki yana lalata estrogens don kawar dasu. Ruwan juicea Graan itacen inabi kamar yana rage yadda sauri jiki ke rushe estrogens kuma yana ƙara yawan estrogen da jiki yake sha. Shan ruwan inabi yayin shan estrogens na iya kara matakan estrogen da kuma illolin da ke tattare da estrogen kamar su kansar nono.

Wasu kwayoyin estrogen sun hada da conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol (Climara, Vivelle, Estring), da sauransu.
Shirye-shirye (VePesid)
Auren peapean inabi na iya rage nawa etoposide (VePesid) da jiki ke sha. Shan ruwan inabi yayin shan etoposide (VePesid) na iya rage tasirin etoposide (VePesid). Don kauce wa wannan hulɗar, raba shan wannan magani daga cin inabi ta aƙalla awanni 4.
Halofantrine
Jiki yana rushe halofantrine don kawar da shi. Ruwan juiceapean itacen inabi kamar yana rage yadda sauri jiki ke rushe halofantrine. Shan ruwan inabi yayin shan halofantrine na iya kara matakan halofantrine da illolin dake tattare da halofantrine, gami da bugun zuciya mara kyau.
Distance Ga-Rankuwa-Lovastatin (Mevacor)
Lovastatin (Mevacor) wani nau'i ne na rage ƙwayar cholesterol wanda ake kira "statin." Jiki yana lalata lovastatin (Mevacor) don kawar dashi. Ruwan 'ya'yan itacen inabi na iya rage yadda sauri jiki ke rushe lovastatin (Mevacor). Shan ruwan 'ya'yan itacen inabi yayin shan lovastatin (Mevacor) na iya kara tasiri da illar wannan magani.

Magunguna da hanta suka canza (Cytochrome P450 3A4 (CYP3A4) substrates)
Wasu magunguna ana canza su ta hanta. Ruwan inabi na iya rage yadda hanta ke saurin wargaza wasu magunguna. Shan ruwan inabi yayin shan wasu magunguna da hanta ta lalata na iya kara tasiri da illar wasu magunguna. Kafin shan ruwan inabi, yi magana da mai ba da lafiyar ka idan kana shan duk wani magani da hanta ke canzawa.

Wasu magungunan da hanta ta canza sun hada da lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), da sauran su.
Magunguna don hawan jini (Masu toshe tashar Calcium)
Ruwan inabi na iya ƙara yawan magani don hawan jini da jiki ke sha. Shan ruwan inabi yayin shan wasu magunguna don hawan jini na iya haifar da hawan jininka yayi kasa sosai.

Wasu magunguna don hawan jini sun hada da nifedipine (Adalat, Procardia), verapamil (Calan, Isoptin, Verelan), diltiazem (Cardizem), isradipine (DynaCirc), felodipine (Plendil), amlodipine (Norvasc), da sauransu.
Magunguna da pamfuna ke motsawa cikin ƙwayoyin cuta (Kwayoyin polypeptide masu safarar kwayoyin halitta)
Wasu magunguna suna motsawa ta hanyar famfo a cikin sel. Aba Graa na iya canza yadda waɗannan famfunan suke aiki da rage yadda yawancin magunguna ke sha da jiki. Wannan na iya sa waɗannan magungunan ba su da tasiri. Don kauce wa wannan hulɗar, raba shan waɗannan magunguna daga cin peapean itacen inabi da aƙalla awanni 4.

Wasu daga cikin wadannan magunguna wadanda ake motsawa ta hanyar fanfo a cikin sel sun hada da bosentan (Tracleer), celiprolol (Celicard, wasu), etoposide (VePesid), fexofenadine (Allegra), fluoroquinolone antibiotics, glyburide (Micronase, Diabeta), irinotecan (Camptosar), methotrexate , paclitaxel (Taxol), saquinavir (Fortovase, Invirase), rifampin, statins, talinolol, torsemide (Demadex), troglitazone, da valsartan (Diovan).
Magungunan da zasu iya haifar da bugun zuciya mara kyau (kwayoyi masu tsawaita lokaci na QT)
Apean itacen inabi na iya shafar tasirin zuciyar ku. Peaukar ɗan itacen inabi tare da magunguna wanda zai iya haifar da bugun zuciya mara kyau zai iya haifar da mummunar illa, gami da bugun zuciya mara kyau.
Wasu magunguna da zasu iya haifar da bugun zuciya mara kyau sun hada da amiodarone (Cordarone), disspyramide (Norpace), dofetilide (Tikosyn), ibutilide (Corvert), procainamide (Pronestyl), quinidine, sotalol (Betapace), thioridazine (Mellaril), da sauran su.
Magungunan da ake amfani dasu don rage cholesterol (Statins)
Jiki yana farfasa wasu magungunan rage cholesterol da ake kira "statins" don kawar dasu. Juiceauren peapean itacen inabi na iya rage yadda sauri jiki ke rushe “statins”. Shan ruwan inabi yayin shan wasu "statins" na iya kara tasiri da illolin wadannan magunguna.
Apean itacen inabi kamar yana rage yadda sauri jiki ke farfasa wasu "statins" gami da lovastatin (Mevacor), simvastatin (Zocor), da atorvastatin (Lipitor).
Methadone (Dolophine)
Jiki yana farfasa methadone (Dolophine) don kawar dashi. Ruwan inabi na iya rage yadda sauri jiki ke farfasa methadone (Dolophine). Shan ruwan inabi yayin shan methadone (Dolophine) na iya kara tasiri da illar methadone (Dolophine).
Methylprednisolone
Jiki yana rushe methylprednisolone don kawar da shi. Ruwan inabi na iya rage yadda sauri jiki ke kawar da methylprednisolone. Shan ruwan inabi yayin shan methylprednisolone na iya kara sakamako da illa na methylprednisolone.
Praziquantel (Biltricide)
Jiki yana rushe praziquantel (Biltricide) don kawar da shi. Ruwan 'ya'yan inabi na iya rage yadda sauri jiki ke farfasa praziquantel (Biltricide). Shan ruwan inabi yayin shan praziquantel (Biltricide) na iya kara tasiri da tasirin praziquantel (Biltricide).
Quinidine
Jiki yana rushe quinidine don kawar da shi. Ruwan inabi na iya rage saurin da jiki ke kawar da quinidine. Shan ruwan inabi yayin shan quinidine na iya kara damar samun sakamako masu illa.
Scopolamine (Yankin Transderm)
Jiki yana lalata scopolamine don kawar da shi. Ruwan inabi na iya rage saurin da jiki ke fasa scopolamine. Shan ruwan inabi yayin shan scopolamine na iya kara sakamako da illa na scopolamine.
Magungunan kwantar da hankali (Benzodiazepines)
Magungunan kwantar da hankula na iya haifar da bacci da bacci. Ruwan inabi na iya rage yadda jiki ke saurin karya wasu magunguna masu sa kuzari. Shan ruwan inabi yayin shan wasu magunguna na kwantar da hankali na iya kara tasiri da illolin wasu magunguna masu kwantar da hankali.

Wasu magunguna masu kwantar da hankali (benzodiazepines) waɗanda zasu iya hulɗa da ruwan anab sun hada da diazepam (Valium), midazolam (Versed), quazepam (Doral), da triazolam (Halcion).
Sildenafil (Viagra)
Jiki yana rushe sildenafil (Viagra) don kawar da shi. Graapea Graan inabi na iya rage yadda sauri jiki ke rushe sildenafil (Viagra). Shan ruwan inabi yayin shan sildenafil (Viagra) na iya kara sakamako da illar sildenafil (Viagra).
Simvastatin (Zocor)
Jiki yana lalata simvastatin (Zocor) don kawar dashi. Ruwan inabi na iya rage yadda sauri jiki ke farfasa simvastatin (Zocor). Shan ruwan inabi yayin shan simvastatin (Zocor) na iya kara tasiri da illar wannan maganin.

Tacrolimus (Shirya)
Jiki yana lalata tacrolimus (Prograf) don kawar dashi. A Graapean inabi na iya rage yadda sauri jiki ke rushe tacrolimus (Prograf).Cin inabi ko shan ruwan anab yayin shan tacrolimus (Prograf) na iya kara tasiri da illar tacrolimus (Prograf). Guji cin inabi ko shan ruwan anab idan kuna shan tacrolimus.
Terfenadine (Seldane)
A Graan itacen inabi na iya ƙara yawan sinadarin terfenadine (Seldane) da jiki ke sha. Shan ruwan inabi yayin shan terfenadine (Seldane) na iya kara sakamako da illar terfenadine (Seldane).
Mawallafi (Brilinta)
Jiki yana lalata ticagrelor (Brilinta) don kawar dashi. Auren howapean itacen inabi na iya rage yadda sauri jiki ke rushe ticagrelor (Brilinta). Shan ruwan inabi yayin shan ticagrelor (Brilinta) na iya kara tasiri da illolin ticagrelor (Brilinta).
Matsakaici
Yi hankali da wannan haɗin.
Aliskiren (Tekturna, Rasilez)
Aliskiren (Tekturna, Rasilez) ana motsa shi ne da fanfuna a cikin ƙwayoyin jiki. A Graan itacen inabi na iya canza yadda waɗannan famfunan suke aiki da rage yawan aliskiren (Tekturna, Rasilez) wanda jiki ke sha. Wannan na iya sa wannan magani ya zama ba shi da inganci. Don kauce wa wannan hulɗar, raba shan wannan magani daga cin inabi ta aƙalla awanni 4.
Blonanserin (Lonasen)
Jiki yana lalata blonanserin (Lonasen) don kawar dashi. Graapean itacen inabi na iya ƙara yawan blonanserin (Lonasen) da jiki ke sha kuma ya rage yadda sauri jiki ke kawar da blonanserin (Lonasen). Shan 'ya'yan inabi yayin shan blonanserin (Lonasen) na iya kara tasirin cutar blonanserin (Lonasen).
Budesonide (Entocort, UCERIS)
Jiki yana rushe budesonide (Pulmicort) don kawar da shi. Abapea na iya yaudarar yadda da sauri jiki ke kawar da budesonide (Pulmicort). Shan 'ya'yan inabi yayin shan budesonide (Pulmicort) na iya kara tasirin budesonide (Pulmicort).
Maganin kafeyin
Jiki yana karya maganin kafeyin don kawar dashi. Graabapea na iya yaudarar yadda jiki yake saurin kawar da maganin kafeyin. Shan giyar inabi yayin shan maganin kafeyin na iya kara illolin kafeyin gami da jin kai, ciwon kai, da bugun zuciya mai sauri.
Colchicine
Jiki yana karya colchicine don kawar dashi. Inabi na iya rage yadda jiki yake saurin kawar da colchicine. Amma wasu bincike sun nuna cewa ‘ya’yan inabi ba sa saurin yadda jiki ke kawar da colchicine. Har sai an san da yawa, bi kowane umarni akan lakabin colchicine dangane da cin ɗanyen inabi.
Dapoxetine (Priligy)
Jiki yana lalata dapoxetine (Priligy) don kawar dashi. Ruwan inabi na iya rage yadda jiki yake saurin kawar dapoxetine (Priligy). Shan ruwan inabi tare dapoxetine (Priligy) na iya ƙara tasirin da tasirin dapoxetine.
Erythromycin
Jiki yana lalata erythromycin don kawar da shi. Inabi na iya rage yadda sauri jiki ke kawar da erythromycin. Shan ruwan 'ya'yan inabi tare da erythromycin na iya kara tasiri da illar erythromycin.
Fexofenadine (Allegra)
Inabi na iya rage yawan fexofenadine (Allegra) da jiki ke sha. Shan ruwan inabi yayin shan fexofenadine (Allegra) na iya rage tasirin fexofenadine (Allegra). Don kauce wa wannan hulɗar, raba shan wannan magani daga cin inabi ta aƙalla awanni 4.
Fluvoxamine (Luvox)
Ruwan 'ya'yan itacen inabi na iya kara yawan kwayar da ke sha ruwa (Luvox). Shan ruwan inabi yayin shan fluvoxamine (Luvox) na iya kara sakamako da illa na fluvoxamine (Luvox).
Itraconazole (Sporanox)
Ana amfani da Itraconazole (Sporanox) don magance cututtukan fungal. Ruwan 'ya'yan inabi na iya shafar yadda itraconazole (Sporanox) na jiki yake sha. Amma babu isasshen bayani don sanin idan wannan hulɗar babbar damuwa ce.
Levothyroxine (Synthroid, wasu)
Levothyroxine (Synthroid, wasu) ana motsa shi da fanfunan cikin ƙwayoyin jiki. Auren pea changean itace na iya canza yadda waɗannan famfunan suke aiki da rage yawan levothyroxine (Synthroid, wasu) waɗanda ke shafan jiki. Wannan na iya sa wannan magani ya zama ba shi da inganci. Don kauce wa wannan hulɗar, raba shan wannan magani daga cin inabi ta aƙalla awanni 4.
Distance Watsa-Losartan (Cozaar)
Hanta tana kunna losartan (Cozaar) don yin aiki. Ruwan inabi na iya rage yadda jiki ke kunna losartan (Cozaar). Shan ruwan inabi yayin shan losartan (Cozaar) na iya rage tasirin losartan.
Magunguna da hanta suka canza (Cytochrome P450 1A2 (CYP1A2) substrates)
Wasu magunguna ana canza su ta hanta. Ruwan inabi na iya rage yadda hanta ke saurin wargaza wasu magunguna. Shan ruwan 'ya'yan inabi tare da wasu magunguna da hanta ta lalata na iya kara tasiri da illar wasu magunguna. Kafin shan ruwan 'ya'yan itacen inabi magana da mai ba da lafiyar ku idan kun sha magunguna wadanda hanta ke canzawa.

Wasu magungunan da hanta ke canzawa sun hada da amitriptyline (Elavil), haloperidol (Haldol), ondansetron (Zofran), propranolol (Inderal), theophylline (Theo-Dur, wasu), verapamil (Calan, Isoptin, wasu), da sauransu.
Magunguna da hanta suka canza (Cytochrome P450 2C19 (CYP2C19) substrates)
Wasu magunguna ana canza su ta hanta. Ruwan inabi na iya rage yadda hanta ke saurin wargaza wasu magunguna. Shan ruwan 'ya'yan inabi tare da wasu magunguna da hanta ta lalata na iya kara tasiri da illar wasu magunguna. Kafin shan ruwan 'ya'yan itacen inabi magana da likitan lafiyar ku idan kun sha magunguna wadanda hanta ke canzawa.

Wasu magungunan da hanta ke canzawa sun hada da omeprazole (Prilosec), lansoprazole (Prevacid), da pantoprazole (Protonix); diazepam (Valium); carisoprodol (Soma); nelfinavir (Viracept); da sauransu.
Magunguna sun canza ta hanta (Cytochrome P450 2C9 (CYP2C9) substrates)
Wasu magunguna ana canza su ta hanta. Ruwan inabi na iya rage yadda hanta ke saurin wargaza wasu magunguna. Shan ruwan 'ya'yan inabi tare da wasu magunguna da hanta ta lalata na iya kara tasiri da tasirin wasu magunguna. Kafin shan ruwan 'ya'yan itacen inabi magana da mai ba da lafiyar ku idan kun sha magunguna wadanda hanta ke canzawa.

Wasu magunguna da hanta ke canzawa sun haɗa da diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), da piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); da sauransu.
Nadolol (Corgard)
Nadolol (Corgard) ana motsa shi da fanfunan cikin ƙwayoyin jiki. Aba Graa na iya canza yadda waɗannan famfunan suke aiki kuma ya rage yadda nadolol (Corgard) yake shiga cikin jiki. Wannan na iya sa wannan magani ya zama ba shi da inganci. Koyaya, wasu bincike sun nuna cewa graa graan itacen inabi ba ya shafan yadda nadolol (Corgard) yake sha a jiki. Har sai an san wasu, bi duk wani umarni akan tambarin nadolol (Corgard) mai alaƙa da cin ɗanyen inabi.
Nilotinib (Tasigna)
Ruwan inabi na iya kara yawan Nilotinib (Tasigna) da jiki ke sha. Shan ruwan inabi yayin shan Nilotinib (Tasigna) na iya kara tasirin da tasirin. Guji shan ruwan anab idan kuna shan Nilotinib (Tasigna).
Oxycodone (Oxycontin)
Jiki yana lalata oxycodone (Oxycontin) don kawar dashi. Ruwan inabi na iya rage yadda sauri jiki ke rushe oxycodone (Oxycontin). Shan ruwan inabi yayin shan oxycodone (Oxycontin) na iya kara sakamako da illar Oxycodone (Oxycontin).
Pitavastatin (Livalo)
Jiki yana lalata pitavastatin (Livalo) don kawar da shi. Juiceauren Graa howan itacen inabi na iya rage yadda sauri jiki ke rushe pitavastatin (Livalo). Shan ruwan inabi yayin shan pitavastatin (Livalo) na iya kara tasiri da illar wannan maganin.

Primaquine
Ruwan inabi na iya ƙara yawan primaquine da ke cikin jiki. Babu tabbacin abin da wannan zai iya haifarwa. Yi hankali da wannan haɗin.
Saquinavir (Fortovase, Invirase)
Shan ruwan inabi na iya kara yawan saquinavir (Fortovase, Invirase) da jiki ke sha. Shan ruwan inabi yayin shan saquinavir (Fortovase, Invirase) na iya kara sakamako da illar saquinavir.
Sertraline (Zoloft)
Jiki yana rushe sertraline don kawar da shi. Inabi na iya rage yadda sauri jiki ke rushe sertraline. Shan ruwan inabi yayin shan sinadarin sertraline na iya kara illoli da kuma illolin da ke tattare da sinadarin.
Sunitinib (Mai Tsargi)
Jiki yana fasa sunitinib (Mai tsayawa) don kawar dashi. Ruwan inabi na iya rage yadda sauri jiki ke rushe sunitinib (Sutent). Shan ruwan inabi yayin shan sunitinib (Sutent) na iya kara sakamako da illar sunitinib (Sutent). Amma wasu bincike sun nuna cewa tasirin ‘ya’yan inabi a kan sunitinib (Sutent) ba babban abin damuwa bane. Har sai an san wasu, bi duk wani umarni akan lakabin sunitinib (Sutent) mai alaƙa da cin ɗanyen inabi.
Talinolol
Ruwan inabi na iya rage yawan talinolol da ke cikin jiki. Shan ruwan inabi tare da talinolol na iya rage tasirin talinolol.
Gagarini
Shan ruwan inabi na iya rage tasirin theophylline. Babu isasshen bayani don sanin idan wannan babban damuwa ne.
Tolvaptan (Samsca)
Jiki ya rushe tolvaptan (Samsca) don kawar da shi. A Graan itacen inabi na iya rage yadda sauri jiki ke rushewar tolvaptan (Samsca). Shan ruwan inabi yayin shan tolvaptan (Samsca) na iya kara illoli da illar tolvaptan (Samsca).
Warfarin (Coumadin)
Ana amfani da Warfarin (Coumadin) don rage saurin daskarewar jini. Shan ruwan inabi na iya kara tasirin warfarin (Coumadin) kuma yana kara damar zafin jini da zubar jini. Tabbatar da ana duba jininka a kai a kai. Za'a iya canza adadin warfarin ku (Coumadin).
Orananan
Yi hankali da wannan haɗin.
Acebutolol (Maɗaukaki)
Acebutolol (Sectral) ana motsa shi da fanfunan cikin ƙwayoyin jiki. Auren peapean itace na iya canza yadda waɗannan famfunan suke aiki kuma ya rage adadin acebutolol (Sectral) wanda jiki yake sha. Wannan na iya sa wannan magani ya zama ba shi da inganci. Don kauce wa wannan hulɗar, raba shan wannan magani daga cin inabi ta aƙalla awanni 4.
Amprenavir (Agenerase)
Apean itacen inabi na iya ɗan rage adadin amprenavir (Agenerase) da jiki ke sha. Amma wannan ma'amala mai yiwuwa ba babbar damuwa ba ce.
Licorice
Shan ruwan inabi lokacin shan licorice na iya kara karfin licorice na haifar da karancin potassium.
Yisti ja
An itacen inabi (ruwan 'ya'yan itace ko' ya'yan itace) yana canza yadda jiki ke sarrafa jan yisti. A Graan itacen inabi na iya ƙara adadin lovastatin daga yisti mai yisti a cikin jini.
Thunder allah kurangar inabi
Thunder allahn itacen inabi ya ƙunshi triptolide. Jiki yana rushe triptolide don kawar da shi. Graa Graapean inabi na iya rage yadda sauri jiki ke rushe triptolide. Shan ruwan inabi yayin shan giyar inabin allah mai tsawa wanda ke dauke da sinadarin triptolide na iya kara sakamako da kuma illa na itacen inabin allah mai tsawa.
Tonic ruwa
Aba Graa na iya tsoma baki tare da yadda jiki ke sarrafa quinine wanda ke cikin ruwan tonic. Mutanen da ke da nakasar zuciya (misali doguwar cutar QT, alal misali) ya kamata su guji shan graa andan itacen inabi da ruwan tonic tare, tun da wannan haɗuwa na iya lalata yanayin zuciyarsu.
Ruwan inabi
Ruwan inabi na iya rage yadda hanta ke saurin wargaza wasu magunguna. Wannan na iya ƙara tasirin tasirin waɗannan magunguna. Redara jan giya a cikin mahaɗin na iya ƙara waɗannan tasirin illa fiye da haka. Farin giya, da alama, ba ze yin hulɗa da ɗan itacen inabi ko magunguna waɗanda hanta ke lalata su.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

DA BAKI:
  • Don kiba: 450-700 MG na takamaiman samfurin dauke da lemu mai zaki, lemu na jini, da ruwan inabi sau biyu a rana tsawon makonni 12 ana amfani da shi. Cin rabin 'ya'yan itacen inabi sau uku a rana, shan wiwi 8 na ruwan' ya'yan inabi sau uku a rana, ko shan kalamu dauke da daskararren busasshen grapef 500 MG sau uku kafin cin abinci tsawon makonni 12 suma an yi amfani dasu.
Bioflavonoid Complex, Bioflavonoid Concentrate, Bioflavonoid Cire, Bioflavonoids, Bioflavonoïdes, Bioflavonoïdes d'grumes, Citrus Bioflavones, Citrus Bioflavonoid, Citrus Bioflavonoid Cire, Citrus Bioflavonoid Cras, Cfrus Bioflavonob, Aka matsa man, Girman ruwan Bioflavonoïde, Cikakken Bioflavonoïde de Pamplemousse, Concentré de Bioflavonoïde, CSE, Bayyan Manyan 'ya'yan inabi, Extrait de Bioflavonoïde, Extrait Bioflavonoïdes d'Agrumes, Extrait de Bioflavonoïdes d'Agrumes, Extrait de Bioflavonoïdes d'Agrumes, Extrait de Grafm 'Agrumes, Kayan Inabi Bioflavonoid hadadden, ractan itacen inabi, Graan itacen inabi, Exta Seedan Graa ,an inabi, Seeda Graan inabi Glycerate, GSE, Huile de Pamplemousse, Huile de Pamplemousse Pressée à Froid, Pampleousse, Pamplesese Rose, Paradpef Man Shaddock, Daidaitaccen Cire 'ya'yan Inabi, Toronja.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. Ershad M, Cruz MD, Mostafa A, Mckeever R, Vearrier D, Greenberg MI. Opioid toxidrome bayan shan ruwan 'ya'yan inabi a cikin saitin gyaran methadone. J Addict Med 2019; [Epub gabanin bugawa]. Duba m.
  2. Chorin E, Hochstadt A, Granot Y, et al. Ruwan peapean itacen inabi ya tsawaita lokacin QT na masu aikin sa kai masu lafiya da marasa lafiya tare da dogon cutar ta QT. Bugun Zuciya. 2019. pii: S1547-527130368-6. Duba m.
  3. Shang DW, Wang ZZ, Hu HT, et al. Hanyoyin abinci da ruwan inabi a kan magunguna guda-guda na maganin blonanserin a cikin batutuwan Sinawa masu lafiya. Eur J Clin Pharmacol. 2018; 74: 61-67. Duba m.
  4. Santes-Palacios R, Romo-Mancillas A, Camacho-Carranza R, Espinosa-Aguirre JJ. Haramtawa ɗan adam da bera CYP1A1 enzyme ta mahaɗan ruwan inabi. Sanarwar Toxicol. 2016 Sep 6; 258: 268-75. Duba m.
  5. Kawaguchi-Suzuki M, Nasiri-Kenari N, Shuster J, et al. Sakamakon amfani da ruwan 'ya'yan itace mai dan-furanocoumarin a kan midazolam pharmacokinetics. J Clin Pharmacol. 2017 Mar; 57: 305-11. Duba m.
  6. Melough MM, Vance TM, Lee SG, et al. Furocoumarin kinetics a cikin plasma da fitsari na lafiyayyun manya biyo bayan cin inabi (citrus paradise Macf.) Da kuma ruwan inabi. J Agric Abincin Chem. 2017 Mar 29 [Epub gaba da bugu] Duba m.
  7. Jia Y, Liu J, Xu J. Tasirin ruwan 'ya'yan inabi a kan magungunan magani na triptolide a cikin berayen ruwan' ya'yan inabi a kan tasirin triptolide. Xenobiotica. 2017 Afrilu 16: 1-5. Duba m.
  8. Abdlekawy KS, Donia AM, Elbarbry F. Hanyoyin inabi da ruwan 'ya'yan rumman a kan kayan magani na dapoxetine da midazolam a cikin batutuwan lafiya. Eur J Drug Metab Pharmacokinet. 2017 Jun; 42: 397-405. Duba m.
  9. Tsuji H, Ohmura K, Nakashima R, et al. Inganci da amincin shan ruwan 'ya'yan itacen inabi tare da maganin tacrolimus a cikin cututtukan mahaifa masu cutar. Intern Med. 2016; 55: 1547-52. Duba m.
  10. Hung WL, Suh JH, Wang Y. Chemistry da kuma tasirin lafiyar furanocoumarins a cikin bishiyar inabi. J Abincin Abincin Abinci. 2017 Janairu; 25: 71-83. Duba m.
  11. Mouly S, Lloret-Linares C, Sellire PO, Sene D, Bergmann JF. Shin dacewar likitanci game da abincin-ƙwayoyi da magungunan ƙwayoyi-tsire-tsire an iyakance da ruwan inabi ne da Saint-John’s Wort? Maganin Pharmacol 2017 Apr; 118: 82-92. Duba m.
  12. Bailey DG. Tsinkaya muhimmancin asibiti game da hulɗar inabi-magani: tsari mai rikitarwa. J Clin Pharm Ther. 2017 Apr; 42: 125-27. Duba m.
  13. Dallas C, Gerbi A, Elbez Y, Caillard P, Zamaria N, Cloarec M. Nazarin asibiti don tantance inganci da amincin citrus polyphenolic cire na jan lemu, bishiyar inabi, da lemu (Sinetrol-XPur) akan sarrafa nauyi da sigogin rayuwa. a cikin lafiyar mutane masu kiba. Phytother Res. 2014 Feb; 28: 212-8. Duba m.
  14. Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX. Tasirin Lipolytic na citrus polyphenolic citt bushewar jan lemu, ɗan itace, lemu (SINETROL) a cikin jikin mutum mai adipocytes. Hanyar aiwatarwa ta hana hana CAMP-phosphodiesterase (PDE). Kwayar cutar shan magani. 2008 Oktoba; 15: 783-92. Duba m.
  15. Dahan A, Amidon GL. Ruwan 'ya'yan itace da' ya'yanta sun kara yawan hanjin ciki na colchicine: hulɗar haɗari mai haɗari da rawar p-glycoprotein. Pharm Res. 2009 Apr; 26: 883-92. Duba m.
  16. Goldbart A, Latsa J, Sofer S, Kapelushnik J. Kusa da mummunar mummunar ƙwayar ƙwayar ƙwayar ƙwayar cuta a cikin yaro. Rahoton harka. Eur J Pediatr. 2000; 159: 895-7. Duba m.
  17. Peterson JJ, Beecher GR, Bhagwat SA, et al. Flavanones a cikin ɓauren inabi, lemuna, da lemun tsami: Haɗawa da sake nazarin bayanan daga adabin nazari. J Abincin Comp Anal. 2006; 19: S74-S80.
  18. Xiao YJ, Hu M, Tomlinson B. Hanyoyin ruwan 'ya'yan inabi a kan maganin cortisol a cikin lafiyayyun samari na Sinawa. Abincin Chem Toxicol. 2014 Dec; 74: 85-90. Duba m.
  19. van Erp NP, Baker SD, Zandvliet AS, Ploeger BA, den Hollander M, Chen Z, den Hartigh J, König-Quartel JM, Guchelaar HJ, Gelderblom H. Marginal haɓaka sunitinib ta ruwan inabi. Ciwon Cancer Pharmacol. 2011 Mar; 67: 695-703. Duba m.
  20. Tapaninen T, Neuvonen PJ, Niemi M. Ruwan 'ya'yan itace na rage yawan ƙwayoyin plasma na OATP2B1 da CYP3A4 substrate aliskiren. Clin Pharmacol Ther. 2010 Sep; 88: 339-42. Duba m.
  21. Tanaka S, Uchida S, Miyakawa S, Inui N, Takeuchi K, Watanabe H, Namiki N. Kwatantawa na tsawon lokaci na hana ruwan 'ya'yan inabi a kan jigilar polypeptide da cytochrome P450 3A4. Biol Pharm Bull. 2013; 36: 1936-41. Duba m.
  22. Shoaf SE, Mallikaarjun S, Bricmont P. Sakamakon ruwan 'ya'yan inabi a kan magunguna na tolvaptan, mai ba da peptide arginine vasopressin antagonist, a cikin batutuwa masu lafiya. Eur J Clin Pharmacol. 2012 Feb; 68: 207-11. Duba m.
  23. Seidegård J, Randvall G, Nyberg L, Borgå O. Hulɗa ruwan 'ya'yan itace tare da budesonide na baka: daidai yake kan sakewa nan da nan da jinkirta-sakin tsari. Pharmazie. 2009 Jul; 64: 461-5. Duba m.
  24. Piccirillo G, Magrì D, Matera S, Magnanti M, Pasquazzi E, Schifano E, Velitti S, Mitra M, Marigliano V, Paroli M, Ghiselli A. Hanyoyin ruwan inabi mai ruwan hoda akan bambancin QT ga marasa lafiya tare da dilated ko hypertensive cardiomyopathy kuma a lafiya batutuwa. Transl Res. 2008 Mayu; 151: 267-72. Duba m.
  25. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT. Juicea juicean itacen inabi na inganta ɗaukar hotuna zuwa oxycodone na baka. Asalin Clinic Pharmacol Toxicol. 2010 Oktoba; 107: 782-8. Duba m.
  26. Misaka S, Miyazaki N, Yatabe MS, Ono T, Shikama Y, Fukushima T, Kimura J. Pharmacokinetic da hulɗar pharmacodynamic na nadolol tare da itraconazole, rifampicin da ruwan inabi a cikin masu sa kai masu lafiya. J Clin Pharmacol. 2013 Jul; 53: 738-45. Duba m.
  27. Ieiri I, Doi Y, Maeda K, Sasaki T, Kimura M, Hirota T, Chiyoda T, Miyagawa M, Irie S, Iwasaki K, Sugiyama Y. Microdosing nazarin asibiti: pharmacokinetic, pharmacogenomic (SLCO2B1), da kuma hulɗa (ruwan inabi mai ruwan inabi) bayanan martaba na celiprolol bayan microdose na baka da maganin warkewa. J Clin Pharmacol. 2012 Jul; 52: 1078-89. Duba m.
  28. Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Hanyoyin ruwan inabi da SLCO1B1 388A> G polymorphism akan kantin magani na pitavastatin. Magungunan Metab Pharmacokinet. 2013; 28: 104-8. Duba m.
  29. Holmberg MT, Tornio A, Neuvonen M, Neuvonen PJ, Backman JT, Niemi M. ruwan 'ya'yan inabi na hana amfani da sinadarai na clopidogrel. Clin Pharmacol Ther. 2014 Mar; 95: 307-13. Duba m.
  30. Holmberg MT, Tornio A, Joutsi-Korhonen L, Neuvonen M, Neuvonen PJ, Lassila R, Niemi M, Backman JT. Ruwan 'ya'yan inabi a hankali yana ƙara yawan ƙwayar plasma da tasirin antiplatelet na ticagrelor a cikin batutuwan lafiya. Br J Clin Pharmacol. 2013 Jun; 75: 1488-96. Duba m.
  31. Abdel-Ghaffar F, Semmler M, Al-Rasheid K, Klimpel S, Mehlhorn H. Inganci na kwayar inabi a kan kwarkwata: gwajin asibiti. Yanayin Parasitol. 2010 Janairu; 106: 445-9. Duba m.
  32. Ionescu G, Kiehl R, Wichmann-Kunz F, da kuma al. Cutar citrus na baka a cikin atamfar eczema: in vitro kuma a cikin vivo karatu akan microflora na hanji. J Orthomol Med 1990; 5: 155-157.
  33. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., da Rouseff, R. L. Flavanone sha bayan naringin, hesperidin, da citrus gwamnati. Clin Pharmacol Ther 1996; 60: 34-40. Duba m.
  34. Pisarik, P. effectara tasirin karfin jini na ƙara ruwan inabi zuwa nifedipine da terazosin a cikin mai haƙuri da tsananin hauhawar jini. Arch Fam.Med 1996; 5: 413-416. Duba m.
  35. Curhan, G. C., Willett, W. C., Rimm, E. B., Spiegelman, D., da Stampfer, M. J. Nazarin binciken amfani da abin sha da kuma barazanar duwatsun koda. Am J Epidemiol. 2-1-1996; 143: 240-247. Duba m.
  36. Cerda, J. J., Normann, S. J., Sullivan, M. P., Burgin, C. W., Robbins, F. L., Vathada, S., da Leelachaikul, P. Rashin hana atherosclerosis ta hanyar abincin pectin a cikin microswine tare da ci gaba da cutar sankarau. Kewaya 1994; 89: 1247-1253. Duba m.
  37. Baekey, P. A., Cerda, J. J., Burgin, C. W., Robbins, F. L., Rice, R. W., da Baumgartner, T. G. Grapefruit pectin ya hana hypercholesterolemia da atherosclerosis a cikin ƙananan alade. Clinioliol Clinic 1988; 11: 597-600. Duba m.
  38. McLundie, A. C. Asarar ƙarancin haƙori na haƙori na yau da kullun da kuma kulawarta tare da kwancen laminates. Maimaitawa. 1991; 7: 43-44. Duba m.
  39. Guo, LQ, Chen, QY, Wang, X., Liu, YX, Chu, XM, Cao, XM, Li, JH, da Yamazoe, Y. Matsayi daban-daban na pummelo furanincoumarin da cytochrome P450 3A5 * 3 polymorphism a cikin makoma da aikin felodipine. Hanyar Hanyar Magunguna ta 2007; 8: 623-630. Duba m.
  40. Ferdman, R. M., Ong, P. Y., da Church, J. A. Pectin anaphylaxis da yiwuwar haɗuwa da rashin lafiyar cashew. Ann.Allergy Asthma Immunol. 2006; 97: 759-760. Duba m.
  41. Fujioka, K., Greenway, F., Sheard, J., da Ying, Y. Sakamakon 'ya'yan inabi akan nauyi da juriya na insulin: dangantaka da cututtukan zuciya. J Abincin 2006; 9: 49-54. Duba m.
  42. Gorinstein, S., Caspi, A., Libman, I., Lerner, HT, Huang, D., Leontowicz, H., Leontowicz, M., Tashma, Z., Katrich, E., Feng, S., da Trakhtenberg, S. Red grapefruit yana da tasiri sosai akan ƙwayar triglyceride a cikin marasa lafiya da ke fama da cutar atherosclerosis: nazarin in vitro da cikin mutane. J Agric Abincin Chem 3-8-2006; 54: 1887-1892. Duba m.
  43. Kumar, A., Teuber, S. S., Naguwa, S., Prindiville, T., da Gershwin, M. E. Eosinophilic gastroenteritis da citrus-induced urticaria. Clin Rev Allergy Immunol 2006; 30: 61-70. Duba m.
  44. Armanini, D., Calo, L., da Semplicini, A. Pseudohyperaldosteronism: hanyoyin pathogenetic. Crit Rev Clin Lab Sci 2003; 40: 295-335. Duba m.
  45. Palermo, M., Armanini, D., da Delitala, G. Ruwan 'ya'yan itace na hana 11beta-hydroxysteroid dehydrogenase a cikin rayuwa, a cikin mutum. Clin Endocrinol. (Oxf) 2003; 59: 143-144. Duba m.
  46. Wangensteen, H., Molden, E., Christensen, H., da Malterud, K. E. Tabbatar da epoxybergamottin a matsayin mai hana CYP3A4 a kwasfa na kwaya. Eur J Clin Pharmacol 2003; 58: 663-668. Duba m.
  47. Trinchieri, A., Lizzano, R., Bernardini, P., Nicola, M., Pozzoni, F., Romano, AL, Serrago, MP, da Confalanieri, S. Sakamakon tsananin ruwan 'ya'yan inabi a kan fitsarin fitsari na citrate da kuma abubuwan da ke tattare da matsalar yin fitsari don dutsen dutse. Yi Digiri. 2002; 34 Gudanar da 2: S160-S163. Duba m.
  48. Sardi, A., Geda, C., Nerici, L., da Bertello, P. [Rhabdomyolysis da hauhawar jini da jijiyoyin jiki suka haifar ta sanadin yawan sinadarin mineralocorticoids: rahoton harka]. Ann Ital Med Int 2002; 17: 126-129. Duba m.
  49. Bailey, D. G., Dresser, G. K., Kreeft, J. H., Munoz, C., Freeman, D.J, da Bend, J. R. Grapefruit-felodipine hulɗar: sakamakon 'ya'yan itace da ba a sarrafa ba da kuma abubuwan da ke iya aiki. Clin Pharmacol Ther 2000; 68: 468-477. Duba m.
  50. Wason, S., DiGiacinto, J. L., da Davis, M. W. Hanyoyin inabi da ruwan lemu na Seville akan kayan magani na colchicine a cikin batutuwan lafiya. Clin Ther 2012; 34: 2161-2173. Duba m.
  51. Kiani, J. da Imam, S. Z. Mahimmancin magani na ruwan inabi da yadda yake hulɗa da magunguna daban-daban. Nutr.J. 2007; 6: 33. Duba m.
  52. Odou, P., Ferrari, N., Barthelemy, C., Brique, S., Lhermitte, M., Vincent, A., Libersa, C., da Robert, H. Grapefruit ruwan 'ya'yan itace-nifedipine hulɗa: yiwuwar shiga cikin mutane da yawa hanyoyin. J Jarin Pharm Ther 2005; 30: 153-158. Duba m.
  53. Desta, Z., Kivisto, K. T., Lilja, J. J., Backman, J. T., Soukhova, N., Neuvonen, P. J., da Flockhart, D. A. Stereoselective pharmacokinetics na cisapride a cikin masu sa kai na lafiya da kuma sakamakon sake gudanar da mulki na ruwan inabi. Br J Clin Pharmacol 2001; 52: 399-407. Duba m.
  54. Kivisto, K. T., Lilja, J. J., Backman, J. T., da Neuvonen, P. J. Maimaita amfani da ruwan inabi da yawa yana ƙara yawan ƙwayar plasma na cisapride. Clin Pharmacol Ther 1999; 66: 448-453. Duba m.
  55. Lilja, J. J., Laitinen, K., da Neuvonen, P.J Hanyoyin ruwan 'ya'yan inabi a kan shayar levothyroxine. Br J Clin Pharmacol 2005; 60: 337-341. Duba m.
  56. Glaeser, H., Bailey, DG, Dresser, GK, Gregor, JC, Schwarz, UI, McGrath, JS, Jolicoeur, E., Lee, W., Leake, BF, Tirona, RG, da Kim, RB Masu safarar miyagun kwayoyi magana da tasirin ruwan 'ya'yan inabi a cikin mutane. Clin Pharmacol Ther 2007; 81: 362-370. Duba m.
  57. Sigusch, H., Henschel, L., Kraul, H., Merkel, U., da Hoffmann, A. Rashin tasirin ruwan 'ya'yan inabi akan diltiazem bioavailability a cikin al'amuran yau da kullun. Pharmazie 1994; 49: 675-679. Duba m.
  58. Paine, MF, Widmer, WW, Hart, HL, Pusek, SN, Beavers, KL, Criss, AB, Brown, SS, Thomas, BF, da Watkins, PB A furanocoumarin-babu ruwan 'ya'yan inabi mai kafa furanocoumarins a matsayin matsakanci na' ya'yan inabi hulɗa-ruwan-felodipine. Am J Clin Nutr 2006; 83: 1097-1105. Duba m.
  59. Yee, G. C., Stanley, D. L., Pessa, L. J., Dalla, Costa T., Beltz, S. E., Ruiz, J., da Lowenthal, D. T. Tasirin ruwan inabi a kan kwayar cyclosporin na jini. Lancet 4-15-1995; 345: 955-956. Duba m.
  60. Schwarz, U. I., Johnston, P. E., Bailey, D. G., Kim, R. B., Mayo, G., da Milstone, A. Tasirin ruwan 'ya'yan itacen citrus mai laushi dangane da ruwan' ya'yan inabi a kan yanayin ciclosporin. Br J Clin Pharmacol 2006; 62: 485-491. Duba m.
  61. Lee, M., Min, D. I., Ku, Y. M., da Flanigan, M. Sakamakon ruwan 'ya'yan inabi a kan kantin magani na microemulsion cyclosporine a cikin batutuwan Afirka na Afirka idan aka kwatanta da batutuwa na Caucasian: shin bambancin kabilanci yana da matsala? J Jarin Pharmacol 2001; 41: 317-323. Duba m.
  62. Ku, Y. M., Min, D. I., da Flanigan, M. Sakamakon tasirin ruwan 'ya'yan inabi a kan kantin magani na microemulsion cyclosporine da kuma maganinsa a cikin masu sa kai na lafiya: shin bambancin tsarin yana da matsala? J Jarin Pharmacol 1998; 38: 959-965. Duba m.
  63. Ducharme, M. P., Warbasse, L. H., da Edwards, D. J. Yin amfani da cyclosporine na cikin jini da na baka bayan an gama gudanarwa tare da ruwan inabi. Clin Pharmacol Ther 1995; 57: 485-491. Duba m.
  64. Bistrup, C., Nielsen, F. T., Jeppesen, U. E., da Dieperink, H. Sakamakon ruwan 'ya'yan inabi akan Sandimmun Neoral sha tsakanin masu karɓar ƙirar allo. Nephrol Kira. Dasawa. 2001; 16: 373-377. Duba m.
  65. Uno, T., Ohkubo, T., Motomura, S., da Sugawara, K. Sakamakon ruwan 'ya'yan inabi a kan yanayin manidipine enantiomers a cikin batutuwa masu lafiya. Br J Clin Pharmacol 2006; 61: 533-537. Duba m.
  66. Rashid, J., McKinstry, C., Renwick, A. G., Dirnhuber, M., Waller, D. G., da George, C. F. Quercetin, in vitro mai hana CYP3A, ba ya ba da gudummawa ga hulɗar tsakanin nifedipine da ruwan inabi. Br J Clin Pharmacol 1993; 36: 460-463. Duba m.
  67. Soons, PA, Vogels, BA, Roosemalen, MC, Schoemaker, HC, Uchida, E., Edgar, B., Lundahl, J., Cohen, AF, da Breimer, DD Ruwan inabi da cimetidine sun hana kwayar halitta ta nitrendipine cikin mutane . Clin Pharmacol Ther 1991; 50: 394-403. Duba m.
  68. Rashid, T. J., Martin, U., Clarke, H., Waller, D.G, Renwick, A. G., da George, C. F. Abubuwan da ke shafar cikakken samar da nifedipine. Br J Clin Pharmacol 1995; 40: 51-58. Duba m.
  69. Lundahl, J., Subsh, C. G., Edgar, B., da Johnsson, G. Hulɗa tsakanin lokacin shan ruwan inabi da tasirinsa kan ilimin kimiyyar magani da magani na felodipine a cikin batutuwan lafiya. Eur J Clin Pharmacol 1995; 49 (1-2): 61-67. Duba m.
  70. Lundahl, J., Subsh, C. G., Edgar, B., da Johnsson, G. Hanyoyin shan ruwan 'ya'yan inabi-pharmacokinetics da haemodynamics na intravenously da kuma maganganun da ake gudanarwa a cikin maza masu lafiya. Eur J Clin Pharmacol 1997; 52: 139-145. Duba m.
  71. Hashimoto, K., Shirafuji, T., Sekino, H., Matsuoka, O., Sekino, H., Onnagawa, O., Okamoto, T., Kudo, S., da Azuma, J. Hulɗa da ruwan citrus tare da pranidipine, sabon maganin antagonist na 1,4-dihydropyridine, a cikin batutuwan lafiya. Eur J Clin Pharmacol 1998; 54 (9-10): 753-760. Duba m.
  72. Fuhr, U., Maier-Bruggemann, A., Blume, H., Muck, W., Unger, S., Kuhlmann, J., Huschka, C., Zaigler, M., Rietbrock, S., da Staib, AH 'Ya'yan itacen inabi na kara yawan nimodipine bioavailability. Int J Clin Pharmacol Ther 1998; 36: 126-132. Duba m.
  73. Goosen, TC, Cillie, D., Bailey, DG, Yu, C., He, K., Hollenberg, PF, Woster, PM, Cohen, L., Williams, JA, Rheeders, M., da Dijkstra, HP Bergamottin Taimakawa ga ɗan itacen inabi-hulɗar felodipine da yanayin mutum. Clin Pharmacol Ther 2004; 76: 607-617. Duba m.
  74. Edgar, B., Bailey, D., Bergstrand, R., Johnsson, G., da Abouth, C. G. M sakamakon shan ruwan 'ya'yan inabi a kan magungunan magani da kuzarin karfi na felodipine - da mahimmancin asibiti. Eur J Clin Pharmacol 1992; 42: 313-317. Duba m.
  75. Christensen, H., Asberg, A., Holmboe, A. B., da Berg, KJ Gudanar da kulawar ruwan 'ya'yan inabi yana kara kamuwa da tsarin diltiazem cikin masu sa kai na lafiya. Eur J Clin Pharmacol 2002; 58: 515-520. Duba m.
  76. Bailey, D. G., Arnold, J. M., Bend, J. R., Tran, L. T., da Spence, J. D. Grapefruit ruwan 'ya'yan itace-felodipine hulɗar juna: sake haifuwa da halayya tare da fadada aikin samar da magani. Br J Clin Pharmacol 1995; 40: 135-140. Duba m.
  77. Bailey, D. G., Arnold, J. M., Munoz, C., da Spence, J. D. Ruwan 'ya'yan itace - hulɗar felodipine: tsari, hangen nesa, da tasirin naringin. Clin Pharmacol Ther 1993; 53: 637-642. Duba m.
  78. Schwarz, U. I., Seemann, D., Oertel, R., Miehlke, S., Kuhlisch, E., Fromm, M. F., Kim, R. B., Bailey, D. G., da Kirch, W. Cincin ruwan 'ya'yan itace yana rage talinolol bioavailability. Clin Pharmacol Ther 2005; 77: 291-301. Duba m.
  79. Sugimoto, K., Araki, N., Ohmori, M., Harada, K., Cui, Y., Tsuruoka, S., Kawaguchi, A., da Fujimura, A. Yin hulɗa tsakanin ruwan 'ya'yan inabi da magungunan tsinkaye: kwatancen triazolam da quazepam. Eur J Clin Pharmacol 2006; 62: 209-215. Duba m.
  80. Hugen, PW, Burger, DM, Koopmans, PP, Stuart, JW, Kroon, FP, van Leusen, R., da Hekster, YA Saquinavir soft-gel capsules (Fortovase) suna ba da ƙaramin tasiri kamar yadda ake tsammani, koda bayan mai mai karin kumallo. Pharm Duniya Sci 2002; 24: 83-86. Duba m.
  81. Culm-Merdek, KE, von Moltke, LL, Gan, L., Horan, KA, Reynolds, R., Harmatz, JS, Kotun MH, da Greenblatt, DJ Sakamakon fadadawa zuwa ruwan 'ya'yan inabi akan aikin cytochrome P450 3A a cikin mutane : kwatanta da ritonavir. Clin Pharmacol Ther 2006; 79: 243-254. Duba m.
  82. Cuong, B. T., Binh, V. Q., Dai, B., Duy, D. N., Lovell, C. M., Rieckmann, K. H., da Edstein, M. D. Shin jinsi, abinci ko ruwan inabi na canza magungunan magani na primaquine a cikin batutuwan lafiya? Br J Clin Pharmacol 2006; 61: 682-689. Duba m.
  83. Charbit, B., Becquemont, L., Lepere, B., Peytavin, G., da Funck-Brentano, C. Pharmacokinetic da hulɗar pharmacodynamic tsakanin ruwan inabi da halofantrine. Clin Pharmacol Ther 2002; 72: 514-523. Duba m.
  84. Lilja, J. J., Neuvonen, M., da Neuvonen, P. J. Hanyoyin amfani da ruwan 'ya'yan inabi na yau da kullun akan kantin magani na simvastatin. Br J Clin Pharmacol 2004; 58: 56-60. Duba m.
  85. Ando, ​​H., Tsuruoka, S., Yanagihara, H., Sugimoto, K., Miyata, M., Yamazoe, Y., Takamura, T., Kaneko, S., da Fujimura, A. Tasirin ruwan inabi akan magunguna na pitavastatin da atorvastatin. Br J Clin Pharmacol 2005; 60: 494-497. Duba m.
  86. Clifford, C. P., Adams, D. A., Murray, S., Taylor, G. W., Wilkins, M. R., Boobis, A. R., da Davies, D. S. Sakamakon cututtukan zuciya na terfenadine bayan hana shi aiki ta hanyar ruwan inabi. Eur J Clin Pharmacol 1997; 52: 311-315. Duba m.
  87. Benton, R. E., Honig, P. K., Zamani, K., Cantilena, L. R., da Woosley, R. L. Ruwan 'ya'yan itace na canza terfenadine pharmacokinetics, wanda ya haifar da tsawaita sake sakewa a kan lantarki. Clin Pharmacol Ther 1996; 59: 383-388. Duba m.
  88. Kawakami, M., Suzuki, K., Ishizuka, T., Hidaka, T., Matsuki, Y., da Nakamura, H. Sakamakon ruwan 'ya'yan inabi a kan magunguna na itraconazole a cikin batutuwa masu lafiya. Int J Clin Pharmacol Ther 1998; 36: 306-308. Duba m.
  89. Lee, A. J., Chan, W. K., Harralson, A. F., Buffum, J., da Bui, B. C. Sakamakon ruwan 'ya'yan inabi akan sinadarin sertraline: in in vitro da in vivo binciken. Clin Ther 1999; 21: 1890-1899. Duba m.
  90. Min, D. I., Ku, Y. M., Geraets, D. R., da Lee, H. Sakamakon ruwan 'ya'yan inabi a kan kantin magani da magani na quinidine a cikin masu sa kai na lafiya. J Jarin Pharmacol 1996; 36: 469-476. Duba m.
  91. Libersa, CC, Brique, SA, Motte, KB, Caron, JF, Guedon-Moreau, LM, Humbert, L., Vincent, A., Devos, P., da Lhermitte, MA Dramatic hana amiodarone metabolism haifar da ruwan inabi ruwan 'ya'yan itace . Br J Clin Pharmacol 2000; 49: 373-378. Duba m.
  92. Kupferschmidt, H. H., Ha, H. R., Ziegler, W. H., Meier, P. J., da Krahenbuhl, S. Saduwa tsakanin ruwan inabi da midazolam a cikin mutane. Clin Pharmacol Ther 1995; 58: 20-28. Duba m.
  93. Hukkinen, S. K., Varhe, A., Olkkola, K. T., da Neuvonen, P. J. Plasma na triazolam sun karu ta hanyar shan ruwan inabi mai haɗuwa. Clin Pharmacol Ther 1995; 58: 127-131. Duba m.
  94. Andersen, V., Pedersen, N., Larsen, N. E., Sonne, J., da Larsen, S. Hanji na farko wucewar metabolism na midazolam a hanta cirrhosis --makamakon ruwan inabi. Br J Clin Pharmacol 2002; 54: 120-124. Duba m.
  95. Sigusch, H., Hippius, M., Henschel, L., Kaufmann, K., da Hoffmann, A. Tasirin ruwan inabi a kan magungunan magani na saurin sakin nifedipine. Pharmazie 1994; 49: 522-524. Duba m.
  96. Hollander, AA, van Rooij, J., Lentjes, GW, Arbouw, F., van Bree, JB, Schoemaker, RC, van Es, LA, van der Woude, FJ, da Cohen, AF Sakamakon ruwan inabi a cyclosporine da kuma prednisone metabolism a cikin marasa lafiya dasawa. Clin Pharmacol Ther 1995; 57: 318-324. Duba m.
  97. Lilja JJ, Raaska K, Neuvonen PJ. Hanyoyin ruwan inabi a kan kantin magani na acebutolol. Br J Clin Pharmacol 2005; 60: 659-63. Duba m.
  98. Yin OQ, Gallagher N, Li A, et al. Hanyoyin ruwan inabi a kan kantin magani na nilotinib a cikin mahalarta masu lafiya. J Clin Pharmacol 2010; 50: 188-94. Duba m.
  99. Benmebarek M, Devaud C, Gex-Fabry M, et al. Hanyoyin ruwan inabi a kan magungunan magani na enantiomers na methadone. Clin Pharmacol Ther 2004; 76: 55-63. Duba m.
  100. Hori H, Yoshimura R, Ueda N, et al. Hullan ruwan inabi-fluvoxamine hulɗa - yana da haɗari ko a'a? J Jarin Psychopharmacol 2003; 23: 422-4. Duba m.
  101. Yasui N, Kondo T, Furukori H, et al. Hanyoyin amfani da ruwan 'ya'yan inabi mai maimaitawa a kan ma'aurata da magunguna masu yawa na kwayoyi da magunguna na alprazolam. Psychopharmacology (Berl) 2000; 150: 185-90. Duba m.
  102. Demarles D, Gillotin C, Bonaventure-Paci S, et al. Hanyoyin magani guda daya na amprenavir wanda aka sarrafa tare da ruwan inabi. Antimicrob Agents Cheamma 2002; 46: 1589-90. Duba m.
  103. Bayanin samfurin don Cordarone. Wyeth Pharmaceuticals, Inc.Philadelphia, PA 19101. Satumba 2006.
  104. Bailey DG, Dresser GK, Leake BF, Kim RB. Naringin babban mai hana magani ne na kwayar cutar polypeptide 1A2 (OATP1A2) a cikin ruwan inabi. Clin Pharmacol Ther 2007; 81: 495-502. Duba m.
  105. Bailey DG. Tsarin ruwan 'ya'yan itace na jigilar kayan abinci: sabon nau'in ma'amala da magani-abinci. Br J Clin Pharmacol 2010; 70: 645-55. Duba m.
  106. Greenblatt DJ. Tattaunawa game da hulɗar miyagun ƙwayoyi da ke tattare da abubuwan sha na 'ya'yan itace da polypeptides masu ɗauke da ƙwayoyin cuta. J Jarin Pharmacol 2009; 49: 1403-7. Duba m.
  107. Dresser GK, Kim RB, Bailey DG. Sakamakon tasirin ruwan 'ya'yan inabi akan rage fexofenadine bioavailability: yuwuwar rawar kwayar cutar jigilar polypeptides. Clin Pharmacol Ther 2005; 77: 170-7. Duba m.
  108. Hanyoyin hulɗa da ƙwayoyi masu yuwuwa tare da itace. Harafin Pharmacist / Wasikar Mai Rubuta 2007; 23: 230204.
  109. Farkas D, Oleson LE, Zhao Y, et al. Ruwan pomegranate baya lalata maganin bakazolam ko na bakin ciki, bincike kan aikin cytochrome P450-3A: kwatankwacin ruwan inabi. J Jarin Pharmacol 2007; 47: 286-94. Duba m.
  110. Monroe KR, Murphy SP, Kolonel LN, Pike MC. Bincike mai zuwa game da cin inabi da kuma barazanar kamuwa da cutar sankarar mama a cikin matan da ba a haifa ba: Mutliethnic Cohort Study. Br J Ciwon 2007; 97: 440-5. Duba m.
  111. Zitron E, Scholz E, Owen RW, et al. QTc tsawaitawa ta ruwan inabi da kuma tushen ilimin hada magunguna: Hanyar HERG ta hanyar flavonoids. Kewaya 2005; 835: 835-8. Duba m.
  112. Unger M, Frank A. Tabbatarwa na lokaci daya na hana ikon fitar da ganyayyaki akan aikin manyan cytochrome P450 enzymes guda shida ta amfani da chromatography na ruwa / masarraban taro da kuma hakar kan layi ta atomatik. Commididdigar Massungiyar Sadarwa ta Commwazo 2004; 18: 2273-81. Duba m.
  113. Fukazawa I, Uchida N, Uchida E, Yasuhara H. Hanyoyin ruwan 'ya'yan itace a kan kantin magani na atorvastatin da pravastatin a Jafananci. Br J Clin Pharmacol 2003; 57: 448-55. Duba m.
  114. Sullivan DM, Ford MA, Boyden TW. Ruwan inabi da amsar warfarin. Am J Lafiya-Syst Pharm 1998; 55: 1581-3. Duba m.
  115. Gaudineau C, Beckerman R, Welbourn S, Auclair K. Rashin hana enzymes na P450 na mutane ta yawancin mahaɗan Ginkgo biloba cire. Biochem Biophys Res Comm 2004; 318: 1072-8. Duba m.
  116. Bailey DG, Dresser GK, Bend JR. Bergamottin, ruwan lemun tsami, da jan giya a matsayin masu hana ayyukan cytochrome P450 3A4: kwatankwacin ruwan inabi. Clin Pharmacol Ther 2003; 73: 529-37. Duba m.
  117. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. Tasirin ruwan inabi da ruwan lemo na seville a kan magunguna na dextromethorphan: rawar gut CYP3A da P-glycoprotein. Rayuwa Sci 2002; 71: 1149-60. Duba m.
  118. Parker RB, Yates CR, Soberman JE, Laizure SC. Hanyoyin ruwan inabi akan P-glycoprotein na ciki: kimantawa ta amfani da digoxin a cikin mutane. Magunguna 2003; 23: 979-87. Duba m.
  119. Shelton MJ, Wynn HE, Hewitt RG, DiFrancesco R. Hanyoyin ruwan 'ya'yan inabi a kan tasirin kantin magani zuwa indinavir a cikin batutuwa masu dauke da kwayar cutar HIV. J Jarin Pharmacol 2001; 41: 435-42. Duba m.
  120. Dresser GK, Bailey DG, Leake BF, da sauransu. Ruwan 'ya'yan itace suna hana jigilar kwayoyin polypeptide-matsakaiciyar magani don rage samuwar baki na fexofenadine. Clin Pharmacol Ther 2002; 71: 11-20. Duba m.
  121. Becquemont L, Verstuyft C, Maimaita R, et al. Tasirin ruwan inabi a kan digoxin pharmacokinetics a cikin mutane. Clin Pharmacol Ther 2001; 70: 311-6. Duba m.
  122. Bailey DG, Dresser GK, Bend JR. Bergamottin, ruwan lemun tsami, da jan giya a matsayin masu hana ayyukan cytochrome P450 3A4: kwatankwacin ruwan inabi. Clin Pharmacol Ther 2003; 73: 529-37. Duba m.
  123. ML na Veronese, Gillen LP, Burke JP, et al. Aƙƙarfan haɓakar dogara ga hanji da hanta CYP3A4 a cikin vivo ta ruwan inabi. J Jarin Pharmacol 2003; 43: 831-9. . Duba m.
  124. Rogers JD, Zhao J, Liu L, et al. Ruwan 'ya'yan itacen inabi yana da tasiri kaɗan akan adadin plasma na 3-hydroxy-3-methylglutaryl coenzyme mai karɓar lovastatin A masu hana haɓaka. Clin Pharmacol Ther 1999; 66: 358-66. Duba m.
  125. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Kayan aiki na ingantaccen wadatar baka na CYP3A4 substrates ta ƙungiyar maɓuran ɓaure. Rage ƙaddarar CYP3A4 mai aiki da inactivation mai ƙarancin aiki ta hanyar furanocoumarins. Magungunan Miyagun ƙwayoyi 1997; 25: 1228-33. Duba m.
  126. Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6 ', 7'-Dihydroxybergamottin a cikin ruwan' ya'yan inabi da ruwan lemu na Seville: illa kan dabi'ar cyclosporine, enterocyte CYP3A4, da P-glycoprotein. Clin Pharmacol Ther 1999; 65: 237-44. Duba m.
  127. Penzak SR, Acosta EP, Turner M, et al. Tasirin ruwan lemu na Seville da ruwan 'ya'yan itace a kan indinavir pharmacokinetics. J Clin Pharmacol 2002; 42: 1165-70. Duba m.
  128. Gupta MC, Garg SK, Badyal D, et al. Hanyoyin ruwan 'ya'yan itace a kan magunguna na theophylline a cikin maza masu sa kai na lafiya. Hanyoyi Nemo Exp Clin Pharmacol 1999; 21: 679-82. Duba m.
  129. Greenblatt DJ, von Moltke LL, Harmatz JS. Lokacin dawowa na aikin cytochrome P450 3A bayan allurai guda na ruwan 'ya'yan inabi. Clin Pharmacol Ther 2003; 74: 121-29. Duba m.
  130. Hermans K, Stockman D, Van den Branden F. Inabi da tonic: haɗuwa mai haɗari a cikin mai haƙuri tare da dogon ciwon QT. Am J Med 2003; 114: 511-512.
  131. Reif S, Nicolson M, Bisset D, et al. Amfanin shan ruwan 'ya'yan itacen inabi a kan bioavailability na rayuwa. Eur J Clin Pharmacol 2002; 58: 491-4 .. Duba m.
  132. Kanazawa S, Ohkubo T, Sugawara K. Sakamakon ruwan 'ya'yan inabi a kan kantin magani na erythromycin. Eur J Clin Pharmacol 2001; 56: 799-803. Duba m.
  133. Fuhr U, Muller-Peltzer H, Kern R, et al. Tasirin ruwan inabi da shan sigari a kan ƙananan verapamil a cikin yanayin kwari. Eur J Clin Pharmacol 2002; 58: 45-53. Duba m.
  134. Ebert U, Oertel R, Kirch W. Rin tasirin ruwan 'ya'yan inabi a kan maganin sikelilamine da kantin magani a cikin lafiyar maza da mata masu lafiya. Int J Clin Pharmacol Ther 2000; 38: 523-31. Duba m.
  135. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, et al. Hanyoyin ruwan inabi a kan kantin magani na sildenafil. Clin Pharmacol Ther 2002; 71: 21-9. Duba m.
  136. Castro N, Jung H, Madina R, et al. Cudanya tsakanin ruwan inabi da praziquantel a cikin mutane. Antimicrob Agents Cheamma 2002; 46: 1614-6. Duba m.
  137. Lilja JJ, Kivisto KT, Neuvonen PJ. Tsawancin tasirin ruwan 'ya'yan itacen inabi a kan magungunan magani na CYP3A4 substrate simvastatin. Clin Pharmacol Ther 2000; 68: 384-90. Duba m.
  138. Bailey DG, Dresser GK. An itacen inabi-hulɗar lovastatin. Clin Pharmacol Ther 2000; 67: 690. Duba m.
  139. Uno T, Ohkubo T, Sugawara K, et al. Hanyoyin ruwan 'ya'yan inabi a kan yanayin kirkirar nicardipine a cikin mutane: hujja don kawar da tsarin tsari mafi girma a cikin hanji. Eur J Clin Pharmacol 2000; 56: 643-9. Duba m.
  140. Ho PC, Ghose K, Saville D, Wanwimolruk S. Sakamakon ruwan 'ya'yan inabi a kan kantin magani da magunguna na verapamil enantiomers a cikin masu sa kai na lafiya. Eur J Clin Pharmacol 2000; 56: 693-8. Duba m.
  141. Chan WK, Nguyen LT, Miller VP, Harris RZ. Rashin aikin inji na mutum cytochrome P450 3A4 ta ruwan inabi da jan giya. Rayuwa Sci 1998; 62: PL135-42. Duba m.
  142. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics da fitsarin fitsari na flavanones naringenin da hesperetin a cikin mutane bayan shan ruwan lemu da ruwan inabi. J Nutr 2001; 131: 235-41. Duba m.
  143. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Hanyoyin ruwan inabi a kan ruwan 'ya'yan itace-hulɗar triazolam: maimaita amfani yana tsawanta rabin rai na triazolam. Eur J Clin Pharmacol 2000; 56: 411-5. Duba m.
  144. Bailey DG, Dresser GK, Munoz C, et al. Rage yawan halittar fexofenadine ta ruwan 'ya'yan itace. Clin Pharmacol Ther 2001; 69: P21.
  145. Dresser GK, Bailey DG, Carruthers SG. An itacen inabi-hulɗar felodipine a cikin tsofaffi. Clin Pharmacol Ther 2000; 68: 28-34. Duba m.
  146. Troisi RJ, Willett WC, Weiss ST, et al. Nazarin mai zuwa game da abinci da asma. Am J Respir Mahimmancin Kula da Lafiya 1995; 151: 1401-8. Duba m.
  147. Butland BK, Fehily AM, Elwood PC. Abinci, aikin huhu, da aikin huhu sun ƙi a cikin ƙungiyar 2512 maza masu matsakaitan shekaru. Thorax 2000; 55: 102-8. Duba m.
  148. Schwartz J, Weiss ST. Dangantaka tsakanin cin abincin bitamin C da aikin huhu a cikin Farkon Kiwon Lafiyar Kiwon Lafiyar Jama'a da Nazarin Gina Jiki (NHANES I). Am J Clin Nutr 1994; 59: 110-4. Duba m.
  149. Carey IM, Strachan DP, Cook DG. Tasirin canje-canje a cikin sabon amfani da 'ya'yan itace akan aikin iska a cikin ƙwararrun Burtaniya masu lafiya. Am J Respir Mahimmancin Kula da Lafiya 1998; 158: 728-33. Duba m.
  150. Kama GE. Asthma, shaƙar ƙwayoyin cuta, da kuma antioxidants masu cin abinci. Am J Clin Nutr 1995; 61: 625S-30S. Duba m.
  151. Forastiere F, Pistelli R, Sestini P, et al. Amfani da sabbin fruita fruitan itace masu wadataccen bitamin C da alamomin nakuda a yara. Thorax 2000; 55: 283-8. Duba m.
  152. Von Woedtke T, Schluter B, Pflegel P, da al. Abubuwan da ke tattare da ingancin ƙwayoyin cuta na ƙwayoyin inabi da alaƙar da ke tattare da abubuwa masu kiyayewa. Pharmazie 1999; 54: 452-6. Duba m.
  153. Ionescu G, Kiehl F, Wichmann-Kunz F, et al. Cutar citrus na baka a cikin atamfar eczema: in vitro kuma a cikin vivo karatu akan microflora na hanji. J Orthomolec Med 1990; 5: 155-7.
  154. Ranzani MR, Fonseca H. Bincike na ilmin lissafi na maganin gyaɗa wanda ba a cire shi ba. Addarin Abincin Abincin 1995; 12: 343-6. Duba m.
  155. Calori-Domingues MA, Fonseca H. Nazarin dakin gwaje-gwaje na sarrafa sinadarai na samar da sinadarin aflatoxin a cikin gyada da ba a kwance ba (Arachis hypogaea L.). Abincin Abincin Abincin 1995; 12: 347-50. Duba m.
  156. Sakamoto S, Sato K, Maitani T, Yamada T. [Tattaunawa game da abubuwan da ke cikin kayan abinci na ɗabi'a "tsinkayen 'ya'yan inabi" na HPLC da LC / MS. Eisei Shikenjo Hokoku 1996;: 38-42. Duba m.
  157. Xiong H, Li Y, Slavik MF, Walker JT. Fesa fatar kaza tare da zaɓaɓɓun sunadarai don rage haɗar Salmonella typhimurium. J Abincin Abincin 1998; 61: 272-5. Duba m.
  158. He K, Iyer KR, Hayes RN, et al. Rashin aiki na cytochrome P450 3A4 ta bergamottin, wani ɓangare na ruwan inabi. Chem Res Toxicol 1998; 11: 252-9. Duba m.
  159. Coreg monograph. A cikin: Gillis MC, Ed. Compendium na Magunguna da Musamman (CPS). 34th ed. Ottawa, Ontario, CAN: Kanada Pharmacists Assn, 1999: 395.
  160. Dresser GK, Spence JD, Bailey DG. Sakamakon Pharmacokinetic-pharmacodynamic da muhimmancin asibiti na hanawa P450 3A4 na cytochrome. Clin Clinicokinet 2000; 38: 41-57. Duba m.
  161. Takanaga H, Ohnishi A, Matsuo H, et al. Nazarin Pharmacokinetic na hulɗar ruwan 'ya'yan itace na felodipine-grapefruit dangane da samfurin hana enzyme wanda ba za a iya sakewa ba. Br J Clin Pharmacol 2000; 49: 49-58. Duba m.
  162. Takanaga H, Ohnishi A, Murakami H, et al. Dangantaka tsakanin lokaci bayan shan ruwan 'ya'yan inabi da tasirin tasirin kantin da sinadarai na nisoldipine a cikin batutuwan lafiya. Clin Pharmacol Ther 2000: 67: 201-14. Duba m.
  163. Damkier P, Hansen LL, Brosen K. Sakamakon diclofenac, disulfiram, itraconazole, ruwan inabi da erythromycin a kan magunguna na quinidine. Br J Clin Pharmacol 1999; 48: 829-38. Duba m.
  164. van Agtmael MA, Gupta V, van der Graaf CA, van Boxtel CJ. Tasirin ruwan inabi a kan rashi dogaro da lokaci na matakan plasma na artemether a cikin batutuwan lafiya. Clin Pharmacol Ther 1999; 66: 408-14. Duba m.
  165. van Agtmael MA, Gupta V, van der Wosten TH, et al. Juiceauren Graa increasesan itacen inabi na ƙara haɓakar halittar artemether. Eur J Clin Pharmacol 1999; 55: 405-10. Duba m.
  166. Ganin J, Kallepalli BR. 'Ya'yan itacen inabi da clomipramine: suna canza canjin yanayi. J Jarin Psychopharmacol 1997; 17: 62-3.
  167. Lambar lantarki na Dokokin Tarayya. Title 21. Kashi na 182 - Abubuwan da Gaba Daya Ganinsu Yana da Lafiya. Akwai a: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  168. Evans AM. Tasirin abubuwan abinci akan abincin ciki da safarar magunguna. Drugungiyar Magunguna ta Ther 2000; 22: 131-6. Duba m.
  169. Fuhr U. Hulɗa da Magunguna tare da Ruwan 'ya'yan itace. Drug Saf 1998; 18: 251-72. Duba m.
  170. Curhan GC, Willett WC, Mai Magana FE, Stamfer MJ. Amfani da abin sha da kuma hadarin tsakuwar koda a cikin mata. Ann Intern Med 1998; 128: 534-40. Duba m.
  171. Ameer B, Weintraub RA. Magungunan ƙwayoyi tare da ruwan inabi. Clin Pharmacokinet 1997; 33: 103-21. Duba m.
  172. Lilja JJ, Kivisto KT, Neuvonen PJ. Hanyoyin 'ya'yan inabi-hulɗar simvastatin: tasiri akan ƙwayoyin maganin na simvastatin, simvastatin acid, da HMG-CoA reductase masu hanawa. Clin Pharmacol Ther 1998; 64: 477-83. Duba m.
  173. Kupferschmidt HH, Fattinger KE, Ha HR, et al. Ruwan 'ya'yan inabi na inganta kwayar halittar mai hana kwayar cutar HIV ta saquinavir a cikin mutum. Br J Clin Pharmacol 1998; 45: 355-9. Duba m.
  174. Lilja JJ, Kivisto KT, Backman JT, et al. Juiceapean itacen inabi na ƙara haɓakar ruwan plasma na buspirone. Clin Pharmacol Ther 1998; 64: 655-60. Duba m.
  175. Fukuda K, Ohta T, Oshima Y, et al. Cayyadaddun masu hana CYP3A4 a cikin ruwan 'ya'yan inabi: furocoumarin dimers azaman abubuwan haɗin hulɗar miyagun ƙwayoyi. Magungunan 1997; 7: 391-6. Duba m.
  176. Zhang YD, Lorenzo B, Reidenberg MM. Rashin hana 11 beta hydroxysteroid dehydrogenase da aka samo daga kodin alade ta furosemide, naringenin da wasu mahaɗan. J Magungunan Biochem Mol Biol 1994; 49: 81-5. Duba m.
  177. Lee YS, Lorenzo BJ, Koufis T, et al. Ruwan inabi da flavonoids na hana 11 beta-hydroxysteroid dehydrogenase. Clin Pharmacol Ther 1996; 59: 62-71. Duba m.
  178. Zaidenstein R, Dishi V, Gips M, et al. Tasirin ruwan inabi a kan magungunan magani na maganin verapamil na baki. Eur J Clin Pharmacol 1998; 54: 337-40. Duba m.
  179. Hanyoyin inabi-magani. Akwai a: www.powernetdesign.com/grapefruit (An shiga 26 Satumba 1999).
  180. Ozdemir M, Aktan Y, Boydag BS. Cudanya tsakanin ruwan inabi da diazepam a cikin mutane. Eur J Drug Metab Pharmacokinet 1998; 23: 55-9. Duba m.
  181. Lilja JJ, Kivisto KT, Neuvonen PJ. Ruwan juicea Graan itacen inabi yana ƙara yawan ƙwayoyin maganin atorvastatin kuma bashi da tasiri akan pravastatin. Clin Pharmacol Ther 1999; 66: 118-27. Duba m.
  182. Babban AS, Goh YD, Addison RS, et al. Tasirin ruwan inabi akan cisapride pharmacokinetics. Clin Pharmacol Ther 1999; 65: 395-401. Duba m.
  183. Varis T, Kivisto KT, Neuvonen PJ. Ruwan inabi na iya ƙara yawan ƙwayar plasma na methylprednisolone. Eur J Clin Pharmacol 2000; 56: 489-93. Duba m.
  184. Cerda JJ, Robbins FL, Burgin CW, et al. Tasirin pectin na grapefruit a kan marasa lafiya da ke cikin haɗarin kamuwa da cututtukan zuciya ba tare da canza abinci ko salon rayuwa ba. Clinioliol 1988; 11: 589-94. Duba m.
  185. Dresser GK, Bailey DG, Carruthers SG. Canjin inabi-hulɗar felodipine a cikin tsofaffi masu lafiya. Clin Pharmacol Ther 1998; 65: (m PIII-63).
  186. Zaidenstein R, Avni B, Dishi V, et al. Tasirin ruwan 'ya'yan itace a kan magunguna na losartan a cikin masu sa kai na lafiya. Clin Pharmacol Ther 1998; 65: (m PI-60).
  187. Soldner A, Kiristoci U, Susanto M, et al. Ruwan inabi yana kunna jigilar magungunan ƙwayoyin P-glycoprotein. Magunguna na 1999; 16: 478-85. Duba m.
  188. Bailey DG, Dresser GK, Kreeft JH, da sauransu. An itacen inabi-hulɗar felodipine: Tasirin sassan da cirewa daga 'ya'yan itacen da ba a sarrafa su ba. Clin Pharmacol Ther 2000; 67: 107 (m PI-71).
  189. Veronese M, Burke J, Dorval E, et al. Ruwan inabi (GFJ) yana hana ƙwayar hanta da hanji CYP3A4 na ciki-dogaro. Clin Pharmacol Ther 2000; 67: 151 (m PIII-37).
  190. Offman EM, Freeman DJ, Dresser GK, da sauransu. Cisapride hulɗa tare da ruwan inabi da jan giya. Clin Pharmacol Ther 2000; 67: 110 (m PI-83).
  191. Robbins RC, Martin FG, Roe JM. Ingantaccen ruwan inabi yana rage hauhawar jini a cikin batutuwa na mutane. Int J Vitam Nutr Sakamakon 1988; 58: 414-7. Duba m.
  192. Rau SE, Bend JR, Arnold MO, et al. Auren 'ya'yan inabi-terfenadine guda-kashi na hulɗa: girma, inji, da dacewa. Clin Pharmacol Ther 1997 61: 401-9. Duba m.
  193. Bailey DG, Arnold JM, Mai ƙarfi HA, et al. Tasirin ruwan inabi da naringin akan nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993; 54: 589-94. Duba m.
  194. Bailey DG, Spence JD, Munoz C, Arnold JM. Hulɗa da ruwan 'ya'yan itacen citrus tare da felodipine da nifedipine. Lancet 1991; 337: 268-9. Duba m.
  195. Kantola T, Kivisto KT, Neuvonen PJ, et al. Ruwan 'ya'yan itace na increasesa greatlyan itacen inabi yana ƙaruwa da ƙwayoyin lovastatin da lovastatin acid. Clin Pharmacol Ther 1998 63: 397-402. Duba m.
  196. Schubert W, Cullberg G, Edgar B, Hedner T. Haramtawa na 17 beta-estradiol metabolism ta hanyar ruwan 'ya'yan inabi a cikin matan ovariectomized. Maturitas 1994; 20: 155-63. Duba m.
  197. Weber A, Jager R, Haihuwar A, et al. Shin ruwan 'ya'yan itace na' ya'yan itace na iya yin tasiri a cikin halittar dan adam? Tsarin haihuwa 1996; 53: 41-7. Duba m.
  198. Garg SK, Kumar N, Bhargava VK, Prabhakar SK. Tasirin ruwan 'ya'yan itace a jikin kwayar carbamazepine a cikin marasa lafiya masu cutar farfadiya. Clin Pharmacol Ther 1998; 64: 286-8. Duba m.
  199. Josefsson M, Zackrisson AL, Ahlner J. Sakamakon ruwan 'ya'yan inabi a kan kantin magani na amlodipine a cikin masu sa kai na lafiya. Eur J Clin Pharmacol 1996; 51: 189-93. Duba m.
  200. Ioannides-Demos LL, Christophidis N, et al. Yin tasiri game da hulɗar asibiti tsakanin ruwan 'ya'yan inabi da cyclosporine da ƙaddarawa a cikin marasa lafiya da cututtukan autoimmune. J Rheumatol 1997; 24: 49-54. Duba m.
  201. Agri Res Svc: Dokta Duke na tsarin halittar jiki da kuma bayanan kimiyyar halitta. www.ars-grin.gov/duke (An shiga 3 Nuwamba 1999).
  202. Penzak SR, Gubbins PO, Gurley BJ, et al. Ruwan 'ya'yan itacen inabi yana rage yawan kwantancin itraconazole a cikin masu sa kai na lafiya. Drugungiyar Magunguna ta Ther 1999; 21: 304-9. Duba m.
  203. Brinker F. Herb Contraindications da Maganganun Miyagun ƙwayoyi. 2nd ed. Sandy, KO: Litattafan Kiwon Lafiyar Jama'a, 1998.
Binciken na ƙarshe - 03/24/2020

Shawarar Mu

Wurin Al'aada: Abubuwa 11 Kowace Mace Ya Kamata Ta Sani
Kiwon Lafiya

Wurin Al'aada: Abubuwa 11 Kowace Mace Ya Kamata Ta Sani

Mun haɗa da kayayyakin da muke t ammanin una da amfani ga ma u karatu. Idan ka iya ta hanyoyin yanar gizo a wannan hafin, zamu iya amun ƙaramin kwamiti. Ga t arinmu. Menene al'ada?Matan da uka wuc...
Shin Yarinyar ta na da Jinkirin Jawabi?
Kiwon Lafiya

Shin Yarinyar ta na da Jinkirin Jawabi?

Aan hekaru 2 na al'ada na iya faɗin kalmomi 50 kuma yayi magana da jimloli biyu da uku. Da hekara 3, kalmomin u na ƙaruwa zuwa ku an kalmomi 1,000, kuma una magana da jimloli uku da huɗu. Idan yar...